RxPeps Direct has prescribed more than 5,000 peptides in just five months, the company said, a milestone that comes as it offers patients a flat $39 medical review and wholesale pricing on medications from a U.S. compounding pharmacy.
The Fort Collins, Colorado-based company provides medical care and reviews for people seeking compounded peptides, a market that has drawn more attention following an HHS push to allow consumers to get prescribed compounded peptides. RxPeps Direct positions itself as a care-first alternative to online peptide, TRT, HRT, and GLP-1 companies that have historically charged a flat rate for medications.
“Patients spoke, and we listened. People want a live video session with a licensed medical provider trained in Peptides. With this program, patients get a monthly live video session for a custom protocol based on their goals, provider check-ins, unlimited messaging, up to 10 prescriptions for compounded peptides, and a goal-based nutritional plan,” said Marcus Hansen, CEO of RxPeps Direct.
That $99 per month concierge-style peptide program allows up to 10 prescriptions. A standard medical review costs $39 and includes up to 3 peptides. Patients then pay the pharmacy directly at the wholesale price. The company said the model contrasts with competitors that charge a flat rate for the medication itself. For example, BPC-157 often carries a $299 price tag from such companies, while the medication costs $95 delivered, according to RxPeps Direct. Those companies make money on both the medical review and the medication, the company said.
RxPeps Direct charges patients for the medical review and then lets them pay the pharmacy directly at wholesale. This approach places patients above profits, not just in marketing text, but in action, Hansen said.
Patients who use compounded peptide medical review through RxPeps Direct work with a licensed medical provider who reviews their health history and builds a protocol based on their goals. The service is aimed at Americans who want a real medical provider to oversee their peptide use and who want to pay wholesale from a U.S. compounding pharmacy.
When RxPeps Direct launched, most peptide users were using research-use-only chemicals with “Not For Human Consumption” written on the vial. There was no medical oversight, no dosing guidance, and no one to call if something went wrong. The company began providing real care to people currently using peptides, offering a standard medical review for $39 and the $99 per month concierge-style peptide program.
The $39 review includes up to three peptides, while the $99 program includes up to 10 prescriptions for compounded peptides, a monthly live video session for a custom protocol based on the patient's goals, provider check-ins, unlimited messaging, and a goal-based nutritional plan.
RxPeps Direct's five-month milestone of over 5,000 peptides prescribed reflects demand for a model that separates the cost of medical care from the cost of medication, the company said. Patients pay the medical review fee and then pay the pharmacy directly at the wholesale price, a structure the company says places patients above profits.